Specialty Pharmacy

Top articles from the leading specialty pharmacy journal.

Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.

Patients who received golimumab and methotrexate reported larger improvements than monotherapy patients.

When the virus enters the nervous system it can affect attention, memory, and language.

Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).

Experimental personalized peptide cancer vaccine found to extend overall survival.

Top recent news in cancer drug development.

MS drug previously refused market authorization because of cancer concerns.

Therapeutic vaccine may reduce cervical cancer by fighting disease after infection.

Tofacitinib effective in the treatment of moderate to severe atopic dermatitis.

Synthetic estrogen molecule may have a profound effect on the ability to survive major blood loss.

Top stories of the week on Specialty Pharmacy Times.

Near-fatal car accident leads man down long journey from infection to cure for hepatitis C.

Small molecules that suppress cancer development were reduced with methotrexate treatment.

Portrazza plus chemotherapy treats metastatic squamous non-small cell lung cancer in patients who were not previously treated specifically for advanced lung cancer.

Secondary prevention found to be unavailable and unaffordable in 94,919 communities across the world.

Some of the basic research behind NS5B inhibitors reveals an often overlooked, but clinically important difference between Viekira Pak and Harvoni.

Increasing colon cancer awareness could exponentially decrease disease-related deaths.

Overall satisfaction with the total cost of health care has been stable for 14 years.

Novel oral treatment for moderate-to-severe plaque psoriasis deemed an effective option.

Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.

Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.

Opdivo found to improve overall survival compared with other leading cancer therapies.

Extrahepatic manifestations may be important clues in the diagnosis of hepatitis C infection.

Health care professionals can use app to access patient data through HIPAA-compliant dashboards on computers or tablets.

Pfizer and Allergan announce $160 billion merger, which is the second-largest in the healthcare industry's history and the largest to use a controversial tax-saving strategy.

Pharmacies are rated as some of the best places to receive top-notch customer service in America.

Tafinlar plus Mekinist found to improve overall survival in unresectable or metastatic BRAF-mutated melanoma.